Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
复制标题
预靶向单克隆抗体 2D12.5 和 88Y-Janus-2-(对硝基苯甲基)-1,4,7,10-四氮杂环十二烷四乙酸 (DOTA) 在患有 KHJJ 小鼠腺癌的 BALB/c 小鼠中的药代动力学：90Y 放射免疫治疗模型。
作者：
Goodwin,DA;Meares,CF;Watanabe,N;McTigue,M;Chaovapong,W;Ransone,CM;Renn,O;Greiner,DP;Kukis,DL;Kronenberger,SI
